Method Profile

Human Blood–CSF Barrier Chip for PEG and Drug Transport

A two-compartment chip enables separate sampling on vascular and cerebrospinal-fluid sides while measuring barrier permeability, PEG distribution and drug transport.

Brain & Neural ModelsOrgan Chips
Diagram of the vascular and cerebrospinal fluid compartments of a human blood–CSF barrier chip.
Two-compartment human blood–CSF barrier chip, including the vascular and cerebrospinal-fluid chambers and gravity-fed reservoirs. (Brown et al., Frontiers in Pharmacology, 2026, CC BY 4.0)

Research Applications

Investigate entry into the cerebrospinal-fluid compartment, localization of free PEG and barrier changes in a defined human-cell system.

Model & Design

Commercially sourced human primary endothelial and choroid-plexus epithelial cells, tested with at least two cell batches or sources in independent experiments.

Experimental Format

A 1 μm porous PET membrane separates compartments with independent media and gravity-driven perfusion; pump perfusion was also compared.

Model Components

  • Component

    Two-compartment chip and primary cells

    Description

    Endothelial cells on the vascular side and epithelial cells on the cerebrospinal-fluid side.

  • Component

    Barrier and PEG measurements

    Description

    3 kDa dextran permeability, PEG immunoassay and fluorescence imaging.

  • Component

    Drug quantification

    Description

    Mass-spectrometry measurements of chloramphenicol and ceftriaxone on both sides.

Measurements & Endpoints

  • Dextran apparent permeability
  • Cell viability and junction markers
  • PEG concentrations in each compartment
  • Cellular PEG puncta
  • Fraction of drug transported across the barrier

Analysis

Use a 3 kDa dextran permeability criterion of ≤1.55 × 10⁻⁵ cm/s. Measure medium PEG by immunoassay, cellular PEG by imaging and reference-drug transport by mass spectrometry.

Published Evidence

  • Study Design

    Assess barrier stability under gravity perfusion, then compare free-PEG conditions and transport of two reference drugs.

    Study Sample

    Barrier assessment included four independent experiments and 15 chips; each drug-transport arm used five chips.

    Comparison

    Different PEG molecular weights and doses; chloramphenicol versus ceftriaxone, interpreted alongside published human observations.

    Finding

    Fourteen of 15 chips retained barrier function to day 15. PEG localization varied with molecular weight and concentration without a significant change in dextran permeability under tested conditions. Chloramphenicol crossed more readily than ceftriaxone (P = 0.03).

    Interpretation & Limits
    • Only two reference drugs were compared; broad prediction of drug transport was not established.
    • PEG studies used free PEG, not all PEGylated medicines.
    • Longer-term performance and donor-related variation need further testing.

Sources

  1. Microphysiological modeling of the Blood-CSF barrier for biopharmaceutical transport and sequestration: evaluation of PEG-induced accumulation and vacuolation in the choroid plexus epithelium. Frontiers in Pharmacology (2026). ↗